Peptide · Recovery & Tissue Repair
BPC-157 / TB-500 / GHK-Cu
A three-peptide stack that joins BPC-157's localized repair and TB-500's whole-body recovery reach to GHK-Cu's copper-driven collagen layer — aimed at the quality of the tissue you rebuild.
Available by consultation
What it is
Repair & Tissue Stack
This is a compounded three-peptide stack that combines BPC-157 (a body-protection pentadecapeptide studied for localized tendon, joint, and gut-lining repair), TB-500 (a synthetic fragment of Thymosin Beta-4 studied for actin binding and whole-body cell migration), and GHK-Cu (a copper-carrying tripeptide studied for collagen, elastin, and skin-and-tissue remodeling). It sits one rung above our two-peptide BPC-157 / TB-500 recovery stack: same repair-plus-recovery foundation, with GHK-Cu added to support the quality and remodeling of the tissue itself — but without the KPV immune-and-gut layer of our four-peptide formula. It is prescribed only when a licensed provider determines it is clinically appropriate for you.
Each peptide in this stack is studied on a different scale, and the rationale for combining all three is that their researched pathways hand off to one another — local repair signal, systemic migration reach, and matrix quality. Here is what each one contributes.
BPC-157 — the localized repair signal
The body-protection pentadecapeptide anchors the stack at the site of concern. It is studied for amplifying local repair signaling — VEGFR2 and nitric-oxide pathways tied to new microvessel formation, plus fibroblast and growth-factor activity — helping feed a strained tendon, joint, or irritated gut lining the blood supply and scaffolding it needs. On its own it is the most area-specific of the three.
TB-500 — the systemic recovery layer
This is what a BPC-157-only course lacks. TB-500, a synthetic Thymosin Beta-4 fragment, is studied for binding actin and promoting cell migration — helping repair cells travel to where they are needed across the body rather than at a single spot. Because it distributes widely, its research interest sits in whole-body recovery reach, complementing BPC-157's local precision.
GHK-Cu — the tissue-quality upgrade
The third peptide is the reason to choose this stack over the two-peptide version. GHK-Cu carries a bioavailable copper ion to fibroblasts and to copper-dependent lysyl oxidase, the enzyme that cross-links collagen and elastin. Where BPC-157 and TB-500 are studied for driving repair, GHK-Cu is studied for the caliber of the matrix that repair lays down — firmer, better-organized connective tissue and skin, not just faster closure.
Candidacy
A considered fit, not a funnel.
This stack suits active adults who want more than speed of recovery — they care about how the rebuilt tissue holds up, and they want a whole-body reach rather than a single-site fix. It is a natural step up for someone who has considered the two-peptide BPC-157 / TB-500 stack but wants the added GHK-Cu collagen-and-matrix layer, while still preferring to stop short of the four-peptide formula that folds in KPV for immune and gut-inflammatory goals. It supports recovery and tissue quality; it does not replace orthopedic, surgical, or dermatologic care. A licensed provider reviews your history to confirm it fits.
- Active adults recovering from soft-tissue strain who also care about tissue quality, not just speed
- People wanting TB-500's systemic recovery reach layered with GHK-Cu's collagen and skin-tissue remodeling
- Those choosing a step above the two-peptide BPC-157 / TB-500 stack but below the four-peptide KPV formula
- Anyone with an active or recent cancer diagnosis, given the angiogenic and cell-migratory signaling studied for BPC-157 and TB-500
- People with Wilson's disease or another copper-metabolism disorder, due to GHK-Cu's copper load
- Those who are pregnant, breastfeeding, or with known hypersensitivity to any component or diluent
Expected Timeline
What to expect
Because this stack blends fast-moving repair peptides with GHK-Cu's slower matrix remodeling, protocols run long enough for the collagen layer to show — recovery and recovery-reach often register first, while tissue quality tends to accumulate behind them.
- 01
Weeks 1-2
Initiation
Your provider establishes the combined protocol and confirms tolerability across all three peptides. BPC-157 is often dosed daily and sometimes near the area of concern; TB-500 typically follows a loading-then-maintenance cadence; GHK-Cu is dosed for steady copper exposure. Routes and dosing are set to your goals.
- 02
Weeks 3-8
Active repair & recovery
The core window where BPC-157 and TB-500 are run together for localized and systemic recovery. GHK-Cu runs alongside on a steady schedule as fibroblasts ramp collagen and matrix output — early changes here tend to show in recovery and mobility rather than visible tissue remodeling.
- 03
Weeks 8-16+
Remodel, taper & reassess
The GHK-Cu matrix layer continues to work as the connective-tissue scaffold reorganizes, while the repair peptides are commonly wound down. Your provider decides whether to taper, hold a maintenance approach, or stop.
Response varies from person to person, and this is a compounded, provider-directed stack. Dose, route, sequencing, and duration for each of the three peptides are set and adjusted by your prescriber — the cadence above is illustrative, not a promise of any particular result.
The Science
Why clinicians reach for it.
The evidence for each peptide here is largely preclinical and early-stage, and no trial has studied this exact three-peptide combination. We describe the direction of research honestly — no invented studies, no promised outcomes.
Three distinct, complementary mechanisms
The rationale for the stack is mechanistic, not statistical: BPC-157's local angiogenic and growth-factor signaling, TB-500's actin-binding and cell-migration role, and GHK-Cu's copper-dependent collagen and elastin remodeling are each studied for a different part of recovery. They are combined because their researched pathways overlap little and complement much.
GHK-Cu is the distinguishing layer
GHK-Cu is one of the more extensively characterized copper peptides, present naturally in human plasma and declining with age. Its high-affinity copper binding feeds the enzymes that cross-link collagen and elastin — precisely the tissue-quality dimension the two-peptide BPC-157 / TB-500 stack does not address.
Not FDA-approved
None of these three peptides is an FDA-approved drug, and this combination is available only through compounding when a licensed provider deems it appropriate. It should be viewed as an emerging, supportive stack — not an established treatment for any condition.
Our Standard of Care
Real transformation, with a friendly team that stands by you every step.
- 01.Provider-Supervised
- Licensed providers review your health profile and guide every treatment decision. You only move forward when a plan is right for you.
- 02.Personalized Plans
- GLP-1 and peptide protocols are titrated to your biology and your goals. No one-size-fits-all, no guesswork.
- 03.We Stand By You
- From eligibility review to ongoing check-ins, our care team supports you throughout your transformation — discreet shipping and secure messaging included.
Clinical Safety
No therapy is right for everyone.
What to know
Reported effects across these peptides are generally mild and often local: injection-site redness, tenderness, or itching, and occasional lightheadedness, fatigue, or nausea. Because GHK-Cu delivers copper, providers dose with cumulative copper exposure in mind. Human safety data for all three — and especially for the combination — is limited, so report any new or persistent symptom to your provider promptly.
Contraindications
This stack is not appropriate during pregnancy or breastfeeding, or for anyone with known hypersensitivity to any component or diluent. Given the angiogenic and cell-migratory signaling studied for BPC-157 and TB-500, it is generally avoided in anyone with an active or recent malignancy. GHK-Cu's copper load makes it unsuitable for people with Wilson's disease or other copper-metabolism disorders. Share your full medical history — including any cancer or liver history and all copper-containing supplements — so your provider can assess suitability.
MagsRX protocols are prepared by partner compounding pharmacies in the United States. Compounding pharmacies are regulated by both state boards and the FDA and have been part of American medicine since long before mass-manufactured drugs existed. The active ingredient is prepared per your protocol — supervised by your provider — and delivered direct to your door.
Frequently Asked
Questions worth asking before you begin.
The repair-plus-recovery foundation is the same: BPC-157 for localized tissue and gut-lining repair, TB-500 for systemic cell migration and whole-body recovery. This version adds GHK-Cu, a copper tripeptide studied for collagen, elastin, and matrix remodeling — a layer aimed at the quality of the tissue you rebuild, not just how quickly it recovers. If tissue and skin quality matter to you alongside recovery, this is the step up.
By design. KPV is studied for immune and gut-inflammatory signaling, and our four-peptide formula (BPC-157 / GHK-Cu / KPV / TB-500) adds it for people with those goals. This three-peptide stack keeps BPC-157, TB-500, and GHK-Cu but leaves KPV out — for those who want the repair-plus-remodel layers without the added immune-and-gut component. Your provider can help you choose between them.
No. None of the three peptides acts on the pituitary or growth-hormone axis, which is what separates this stack from GH-support peptides like Sermorelin or Ipamorelin. BPC-157 and TB-500 are studied for local and systemic repair signaling, and GHK-Cu works as a copper-carrying signaling peptide — recovery and tissue remodeling rather than any hormonal effect.
Explore More
Other therapies to consider.
Tissue RepairBPC-157
A body-protection pentadecapeptide studied for how it may support the slow-healing places — a strained tendon, an irritable gut lining, a joint that lingers.
Learn more →- Recovery Stack
BPC-157 / TB500
A two-peptide recovery stack that pairs BPC-157's localized repair focus with TB-500's systemic reach — so support isn't confined to one strained spot but extends across the soft tissue that moves with it.
Learn more → - Tissue Repair
BPC-157 Acetate
The same BPC-157 pentadecapeptide, prepared as the acetate salt — the biocompatible counter-ion chosen for a clean compounded preparation that avoids residual TFA.
Learn more →
Begin
BPC-157 / TB-500 / GHK-Cu begins with a short assessment.
A licensed provider reviews every order and prescribes only if it is clinically appropriate for you. Your therapy is prepared by a partner compounding pharmacy and delivered discreetly to your door.